By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Named Patient Programs: Key Facts You Should Know
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health care > Named Patient Programs: Key Facts You Should Know
Health care

Named Patient Programs: Key Facts You Should Know

Learn key facts about Named Patient Programs (NPPs), including access to medications and benefits for patients and healthcare providers. Stay informed today!

Aises Jammy
Aises Jammy
Share
6 Min Read
named patient programs
Licensed Image from DepositPhotos - 363061354
SHARE

The named patient program (NPP) allows patients and doctors to market authorized pharmaceuticals inside their own country. To get these pharmaceuticals approved under the NPP in at least one country, the patient must first provide their permission. As a result of constantly changing lifestyles and rising stress levels, the incidence of rarer and more unique illnesses has increased.

Contents
  • Uses of the Named Patient Program
  • What’s the Difference between Compassionate Use and Named Patient Programs? 
  • Named Patient Programs in Different Countries
  • Conclusion

At the same time, as patients and doctors become more aware of unlicensed pharmaceuticals and utilize social media and the internet to obtain and spread medical information, the named patient program receives more attention.

 According to the World Health Organization’s (WHO) definition, some illnesses require the use of unlicensed medicines, orphan pharmaceuticals, or novel therapies. The market quickly fills the unmet need for these therapies.

Uses of the Named Patient Program

 The named patient program benefits all pharmaceutical sponsors. In most situations, sponsors want to launch their products in major markets where they can reach a larger number of patients, as well as in well-established pharmaceutical marketplaces in nations like the United States of America, Europe, Japan, and other big ones. 

More Read

What Does A Medical Malpractice Attorney Do? Here’s What To Know
Why Preventative Care Is More Important Than Ever
Leading People to Healthy Living through Blogging
How Acupuncture Helps Cure Infertility and Aid in Pregnancy
3 Dangerous Health Care Myths that Just Won’t Go Away

The right to access, acquire, and import medications that have the potential to save the patient’s life or improve the patient’s quality of life is granted to a patient from any country who is identified as “the named patient” and suffers from a chronic, severe, or life-threatening illness. On the other hand, the rules and regulations governing the importation of innovative medications differ from country to country. Each country must follow its restrictions while importing such drugs. Several existing programs, such as the Named Patient Import Program, the Early Access Program, and the Compassionate Use Program, aim to accelerate the importation of these medications. Nonetheless, each country follows its national agenda.

The named patient program (NPP) allows patients and clinicians in the United States access to commercially approved pharmaceuticals that they would not be able to get in their native country. The named patient program (NPP) requires approval of certain drugs in at least one country before allowing their import into the patient’s country.

What’s the Difference between Compassionate Use and Named Patient Programs? 

Both programs serve patients who have serious conditions and need emergency medical attention. When no other treatment choices are available, the programs allow participants to get experimental or unapproved drugs. Neither of these programs is confined to a single patient, although they may be used with a small group of patients.

Health agencies such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA) supervise these operations on a national or worldwide level. Before the patient or patients in question may access the medicine, physicians must apply for approval and undergo an ethical examination. 

The national level regulates Named Patient Programs (NPPs). As a result, the criteria may vary across countries. On the other hand, the named patient program (NPP) provides a more efficient and adaptable method for obtaining pharmaceuticals in areas where approval is still pending. A physician may get a drug for a specific patient directly from the manufacturer or a relevant supplier (with the assistance of a registered chemist).

Named Patient Programs in Different Countries

By implementing named patient programs or expanded access programs, the majority of countries around the world have enabled their medical practitioners to supply unlicensed medications that might save their patients’ lives in an emergency. The FDA’s Expanded Access Program (EAP) includes the Named Patient Program in the United States. When it comes to treating life-threatening or crippling illnesses, the CDSCO in India approves the importation of unapproved medications for certain individuals. The European Medicines Agency (EMA) offers Compassionate Use and Named Patient Programs to improve access to unlicensed pharmaceuticals in the European Union. On the other hand, the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom allows named patient imports for applications that match the criteria. In addition, there are named patient and extended access programs in other countries throughout the world, including Africa, South America, Asia, and the Middle East, as well as Australia and New Zealand. These programs allow participants to explore potentially life-saving therapies for life-threatening diseases.

Conclusion

Named patient programs (NPPs) seek to streamline the process of determining the best therapy for a patient’s specific medical needs. There may be a therapy available in your region that is just as useful. On the other hand, it is encouraging to know that there are further choices available for patients who have exhausted all local options or who have a unique illness that is now in the “waiting room” for therapeutic approval.

TAGGED:named patient program
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

improving patient experience
eHealthHealth care

7 Helpful And Important Tips For Improving Patient Experience

October 5, 2020
preventive healthcare
Health care

Medisera Health Leads the Charge in Preventive Healthcare

March 28, 2024
Health care

Stop Worrying About Your Lifespan – Your Healthspan Really Matters

October 12, 2019
benefits of health insurance
BusinessHealth carePublic Health

7 Incredibly Important Benefits of Purchasing Health Insurance

March 3, 2021
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?